Deltex Medical (GB:DEMG) has released an update.
Deltex Medical Group PLC has launched two new share incentive plans and granted a total of 366.9 million share options to directors and employees to foster investment in the company’s growth and align interests with shareholders. The new schemes replace outdated legacy programs, setting performance conditions based on achieving certain EBITDA targets. In a move to ensure alignment with shareholder interests, executive directors have waived their rights to the previous schemes’ options, reinforcing their commitment to the company’s future profitability.
For further insights into GB:DEMG stock, check out TipRanks’ Stock Analysis page.
